Reversible tardive dyskinesia: implications for therapeutic strategy and prevention of tardive dyskinesia.
D000818:Animals; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002428:Cebus; D003431:Cross-Cultural Comparison; D004195:Disease Models, Animal; D004219:District of Columbia; D004409:Dyskinesia, Drug-Induced; D006801:Humans; D007194:India; D007700:Kinetics; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D051381:Rats; D012075:Remission, Spontaneous; D013375:Substance Withdrawal Syndrome; D013997:Time Factors
D014150:Antipsychotic Agents